Translational Neuroscience MRes

An MRes in Translational Neuroscience provides in-depth training in research methodologies, preparing individuals for advanced research careers in neuroscience, particularly those focused on translating scientific discoveries into clinical applications. This degree equips graduates with the skills and knowledge to bridge the gap between preclinical discovery through to first-time-in-human studies. The programme is delivered by the UCL Queen Square Institute of Neurology, a specialist postgraduate institute and a worldwide centre of excellence in clinical research (REF 2021) across neurological diseases, including movement disorders (e.g. Parkinson's disease), multiple sclerosis, motor neurone disease, neuro-inflammation, epilepsy, stroke, Huntington disease, cognitive dysfunction, Alzheimer's disease and other dementias. Targeting all areas of translational neuroscience, you will engage with and enhance your understanding of the phases of drug development, pre-clinical to clinical research, with a particular focus on “First-in-Human” and early phase clinical trials, study designs and endpoints, biomarkers and safety assessments in clinical trials, principles of Pharmacokinetics, Pharmacodynamics and Pharmacovigilance, research governance, medical statistics and the fundamental principles for using the correct use of enabling technologies within the context of medical research and drug development (e.g. genomics, proteomics, metabolomics, clinical study designs, biomarkers, imaging, electrophysiology, etc). We welcome applications from prospective students who meet our entry requirements, biology-related graduates andor professionals working in the field of clinical trials.

A medical degree (MBBS) or a minimum of an upper second-class UK Bachelor’s degree in life or biomedical sciences (for example, neuroscience, pharmacology or chemistry) or an overseas qualification of an equivalent standard.